The store will not work correctly when cookies are disabled.
2-(4-(2-(5-(2-methoxyphenyl)-1,3,4-oxadiazol-2-ylthio)ethoxy)benzylidene)malononitrile
ID: ALA2296206
PubChem CID: 76323997
Max Phase: Preclinical
Molecular Formula: C21H16N4O3S
Molecular Weight: 404.45
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccccc1-c1nnc(SCCOc2ccc(C=C(C#N)C#N)cc2)o1
Standard InChI: InChI=1S/C21H16N4O3S/c1-26-19-5-3-2-4-18(19)20-24-25-21(28-20)29-11-10-27-17-8-6-15(7-9-17)12-16(13-22)14-23/h2-9,12H,10-11H2,1H3
Standard InChI Key: OSAZHQQWPVYINV-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
18.5106 -4.2318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3260 -4.2330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7329 -3.5285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3255 -2.8224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5070 -2.8252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1038 -3.5303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5501 -3.5287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0295 -4.1871 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.8077 -3.9346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8066 -3.1163 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.0277 -2.8658 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.5234 -4.3288 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
23.2229 -3.9064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2069 -3.0893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9064 -2.6669 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.6220 -3.0615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6327 -3.8764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3475 -4.2710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0480 -3.8485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0292 -3.0272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3140 -2.6364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7641 -4.2421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4631 -3.8187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1792 -4.2124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4460 -3.0017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4321 -2.1891 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.8920 -4.6061 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.7330 -2.1140 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.5502 -2.1128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
3 7 1 0
8 9 1 0
7 8 1 0
9 10 2 0
10 11 1 0
11 7 2 0
9 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
19 22 1 0
22 23 2 0
23 24 1 0
23 25 1 0
25 26 3 0
24 27 3 0
4 28 1 0
28 29 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 404.45 | Molecular Weight (Monoisotopic): 404.0943 | AlogP: 4.35 | #Rotatable Bonds: 8 |
Polar Surface Area: 104.96 | Molecular Species: NEUTRAL | HBA: 8 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.72 | CX LogD: 3.72 |
Aromatic Rings: 3 | Heavy Atoms: 29 | QED Weighted: 0.31 | Np Likeness Score: -1.63 |
References
1. Deora GS, Karthikeyan C, Moorthy NSHN, Rathore V, Rawat AK, Tamrakar AK, Srivastava AK, Trivedi P. (2013) Design, synthesis and biological evaluation of novel arylidine-malononitrile derivatives as non-carboxylic inhibitors of protein tyrosine phosphatase 1B, 22 (11): [10.1007/s00044-013-0528-1] |